Kedrion Biopharma’s Bolognana (Lucca) production plant hosted Farmindustria’s “Innovation and Production of Value” roadshow, an initiative organized – for the fifth year running – by the Italian Association of Pharmaceutical Companies with the aim of showcasing national pharmaceutical excellence.
The day started with a conference entitled “The pharmaceutical industry: an asset Italy can’t afford to lose”, attended by AIFA (the Italian national drugs agency) and Confindustria Toscana (the regional industrial associational), and Regional authorities, union representatives and local institutions, in the course of which the pharmaceutical industry’s numbers were examined, highlighting the excellent results achieved by the regional segment in which Kedrion Biopharma and Menarini – the two companies called to share their business testimonies – operate.
“Tuscany has triggered a virtuous cycle for the development of the pharmaceutical industry” – stated Paolo Marcucci, Kedrion Biopharma President & CEO, during the opening speech – “thanks to a quality regional healthcare system, to the presence of three universities (in Florence, Pisa and Siena) that excel in scientific disciplines, and to local entrepreneurial skills. This development – that so far has progressed of its own accord – now needs to acquire a method and become systematic at an institutional level. The aim of events such as today’s” – Marcucci went on to add – “is to encourage those regional and national institutions, whose support and close involvement we already benefit from, to do even more, in the light of the results achieved by the pharmaceutical industry in Italy, and in Tuscany in particular, especially in terms of exports”.
Marialina Marcucci, Chief Communication Officer and Member of the Board of Directors, took to the stage to tell Kedrion’s story, retracing the milestones of the Marcucci family business, and reviewing the company’s current activities: “Courage, rootedness, respect and transparency are the values that we share with many other Tuscan and Italian businesses: today, these are keywords that define Italian entrepreneurship”.
Company presentations by Kedrion and Menarini, bearing witness to the successes of the Tuscan pharmaceutical industry (“demonstrating the strength of Italian-ness”, in the words of Farmindustria’s President Massimo Scaccabarozzi), were followed by an interesting round table on the topic of governance in the pharmaceutical sector: “The results achieved in recent years” – concluded Scaccabarozzi – “should be safeguarded with determination, and consolidated, which requires new governance rules. This is the only way to guarantee that fair access to treatment continues, to attract investments and to ensure the sustainability of the system”.